Rivastigmine for Alzheimer's disease

Overview of attention for article published in Cochrane database of systematic reviews, September 2015

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 2 posts from 2 blogs.

In this blog for our dementia series, nurse Helen Cowan reflects on Cochrane evidence on rivastigmine and the use of this drug…

Rosalyn Nelson presents the latest Cochrane systematic review of Rivastigmine for Alzheimer’s disease, which brings together…